We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA) Stock Moves -0.62%: What You Should Know
Read MoreHide Full Article
The most recent trading session ended with Walgreens Boots Alliance (WBA - Free Report) standing at $11.21, reflecting a -0.62% shift from the previouse trading day's closing. This move was narrower than the S&P 500's daily loss of 0.76%. At the same time, the Dow lost 1.14%, and the tech-heavy Nasdaq lost 0.18%.
Shares of the largest U.S. drugstore chain witnessed a gain of 13.14% over the previous month, beating the performance of the Retail-Wholesale sector with its loss of 10.64% and the S&P 500's loss of 7.29%.
Market participants will be closely following the financial results of Walgreens Boots Alliance in its upcoming release. The company's earnings per share (EPS) are projected to be $0.53, reflecting a 55.83% decrease from the same quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $37.92 billion, indicating a 2.35% upward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.61 per share and revenue of $151.51 billion. These totals would mark changes of -44.1% and +2.61%, respectively, from last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Walgreens Boots Alliance. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate has moved 0.53% higher within the past month. Walgreens Boots Alliance is currently sporting a Zacks Rank of #2 (Buy).
From a valuation perspective, Walgreens Boots Alliance is currently exchanging hands at a Forward P/E ratio of 7.01. For comparison, its industry has an average Forward P/E of 6.07, which means Walgreens Boots Alliance is trading at a premium to the group.
It is also worth noting that WBA currently has a PEG ratio of 1.4. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. Retail - Pharmacies and Drug Stores stocks are, on average, holding a PEG ratio of 0.85 based on yesterday's closing prices.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 4, which puts it in the top 2% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Stock Moves -0.62%: What You Should Know
The most recent trading session ended with Walgreens Boots Alliance (WBA - Free Report) standing at $11.21, reflecting a -0.62% shift from the previouse trading day's closing. This move was narrower than the S&P 500's daily loss of 0.76%. At the same time, the Dow lost 1.14%, and the tech-heavy Nasdaq lost 0.18%.
Shares of the largest U.S. drugstore chain witnessed a gain of 13.14% over the previous month, beating the performance of the Retail-Wholesale sector with its loss of 10.64% and the S&P 500's loss of 7.29%.
Market participants will be closely following the financial results of Walgreens Boots Alliance in its upcoming release. The company's earnings per share (EPS) are projected to be $0.53, reflecting a 55.83% decrease from the same quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $37.92 billion, indicating a 2.35% upward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.61 per share and revenue of $151.51 billion. These totals would mark changes of -44.1% and +2.61%, respectively, from last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Walgreens Boots Alliance. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate has moved 0.53% higher within the past month. Walgreens Boots Alliance is currently sporting a Zacks Rank of #2 (Buy).
From a valuation perspective, Walgreens Boots Alliance is currently exchanging hands at a Forward P/E ratio of 7.01. For comparison, its industry has an average Forward P/E of 6.07, which means Walgreens Boots Alliance is trading at a premium to the group.
It is also worth noting that WBA currently has a PEG ratio of 1.4. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. Retail - Pharmacies and Drug Stores stocks are, on average, holding a PEG ratio of 0.85 based on yesterday's closing prices.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 4, which puts it in the top 2% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.